Structure-function relationships of ErbB RTKs in the plasma membrane of living 
cells

Arndt-Jovin, D. J.; Gralle Botelho, M.; Jovin, T. M.

doi:10.1101/cshperspect.a008961

Datensatz

DATENSATZ AKTIONENEXPORT

Zur Ablage hinzufügen

Lokale TagsFreigabegeschichteDetailsÜbersicht

Freigegeben

Buchkapitel

Structure-function relationships of ErbB RTKs in the plasma membrane of living cells

MPG-Autoren

/persons/resource/persons14791

Arndt-Jovin, D. J.
Emeritus Group Laboratory of Cellular Dynamics, MPI for Biophysical Chemistry, Max Planck Society;

/persons/resource/persons15286

Jovin, T. M.
Emeritus Group Laboratory of Cellular Dynamics, MPI for Biophysical Chemistry, Max Planck Society;

Externe Ressourcen

Es sind keine externen Ressourcen hinterlegt

Volltexte (beschränkter Zugriff)

Für Ihren IP-Bereich sind aktuell keine Volltexte freigegeben.

Volltexte (frei zugänglich)

Es sind keine frei zugänglichen Volltexte in PuRe verfügbar

Ergänzendes Material (frei zugänglich)

Es sind keine frei zugänglichen Ergänzenden Materialien verfügbar

Zitation

Arndt-Jovin, D. J., Gralle Botelho, M., & Jovin, T. M. (2014). Structure-function relationships of ErbB RTKs in the plasma membrane of living cells. In J. Schlessinger, & M. A. Lemmon (Eds.), Signaling by Receptor Tyrosine Kinases. A subject collection from Cold Spring Harbor Perspectives in Biology (4, pp. 193-206). Cold Spring Harbor, N.Y.: Cold Spring Harbor Lab. Pr.

Zitierlink: https://hdl.handle.net/11858/00-001M-0000-0018-6FC0-4

Zusammenfassung

We review the states of the ErbB family of receptor tyrosine kinases (RTKs), primarily the EGF receptor (EGFR, ErbB1, HER1) and the orphan receptor ErbB2 as they exist in living mammalian cells, focusing on four main aspects: (1) aggregation state and distribution in the plasma membrane; (2) conformational features of the receptors situated in the plasma membrane, compared to the crystallographic structures of the isolated extracellular domains; (3) coupling of receptor disposition on filopodia with the transduction of signaling ligand gradients; and (4) ligand-independent receptor activation by application of a magnetic field.